產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
產(chǎn)品概述
名稱 | JIMT-1 (人乳腺癌細(xì)胞) (STR鑒定正確) |
別稱 | JIMT1; JIMT |
種屬 | 人 |
生長(zhǎng)特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣,單層生長(zhǎng) |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:8 |
推薦換液頻率 | 2-3次/周 |
背景描述 | established from the pleural effusion of a 62-year-old woman with ductal breast cancer (grade 3 invasive, T2N1M0) after postoperative radiation in 2003; cell line was described in the literature to carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drugs, e.g. trastuzumab (Herceptin); listed in the CCLE (ref 18232) |
年齡(性別) | 女性;62歲 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 乳腺導(dǎo)管癌 |
生物安全等級(jí) | BSL-1 |
倍增時(shí)間 | ~30-40 hours (DSMZ=ACC-589); 35.39 hours (GrayJW panel) |
保藏機(jī)構(gòu) | AddexBio; C0006005/50 DSMZ; ACC-589 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 12,13 D2S1338 24 D3S1358 18 D5S818 12,13,14 D7S820 12 D8S1179 10,13 D13S317 8,13 D16S539 11 D18S51 10 D19S433 12,13 D21S11 27,31.2 FGA 21,23 PentaD 9,12 PentaE 7,19 TH01 7 TPOX 8 vWA 18 D6S1043 11 D12S391 17 D2S441 11.3,14 -
STR鑒定圖
-
參考文獻(xiàn)
-
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer (2025-02-14)
期刊:Advanced Science
影響因子 :14.3
引用產(chǎn)品: JIMT-1 細(xì)胞
-
Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors (2024-04-11)
期刊:BIOMEDICINE & PHARMACOTHERAPY
DOI:10.1016/j.biopha.2024.116565
影響因子 :7.5
引用產(chǎn)品: JIMT-1 細(xì)胞
-
Prognostic and immune correlation of IDO1 promoter methylation in breast cancer (2024-11-13)
期刊:Scientific Reports
DOI:10.1038/s41598-024-79149-w
影響因子 :3.8
引用產(chǎn)品: DMEM高糖 培養(yǎng)基 , T-47D 細(xì)胞 , JIMT-1 細(xì)胞 , MDA-MB-231 細(xì)胞 , SUM159PT 細(xì)胞 , MEM完全培養(yǎng)基(含10% FBS) , 特級(jí)胎牛血清 , A549 [A-549] 細(xì)胞 , MCF7 [MCF-7] 細(xì)胞 , ZR-75-1 細(xì)胞 , 青霉素-鏈霉素溶液(雙抗),100× , RPMI-1640 培養(yǎng)基 , HCC1806 細(xì)胞
-
CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1 (2023-12-31)
期刊:Breast Cancer-Targets and Therapy
影響因子 :2.6
引用產(chǎn)品: ZR-75-1 細(xì)胞 , MCF7 [MCF-7] 細(xì)胞 , JIMT-1 細(xì)胞 , MDA-MB-468-06 細(xì)胞 , MDA-MB-231 細(xì)胞 , SK-BR-3 [SKBR3] 細(xì)胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識(shí)別碼示意圖